These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7903593)

  • 21. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy for acute myocardial infarction.
    Rich MW
    Clin Geriatr Med; 1996 Feb; 12(1):141-68. PubMed ID: 8653655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Secondary prevention in chronic coronary heart disease].
    Hunziker P; Bertel O
    Schweiz Med Wochenschr; 1997 Feb; 127(7):254-60. PubMed ID: 9157530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of myocardial reinfarction. Recommendations based on results of drug trials.
    Flaker GC; Singh VN
    Postgrad Med; 1993 Nov; 94(6):94-8, 102-4. PubMed ID: 7901845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological aspects of secondary prevention post-MI].
    Schrör K
    Z Kardiol; 2004; 93 Suppl 1():I1-3. PubMed ID: 15021997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myocardial infarction.
    Danchin N; Urban P; De Benedetti E
    Clin Evid; 2003 Dec; (10):37-63. PubMed ID: 15555085
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myocardial infarction.
    Danchin N; De Benedetti E; Urban P
    Clin Evid; 2003 Jun; (9):22-49. PubMed ID: 15366134
    [No Abstract]   [Full Text] [Related]  

  • 30. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of remodeling of the heart after myocardial infarction.
    Gorlin R
    Mt Sinai J Med; 1995 Sep; 62(4):287-92. PubMed ID: 7565851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Secondary prevention of ischemic cardiopathy].
    Caruzzo E; Caruzzo C
    Cardiologia; 1995 May; 40(5):347-53. PubMed ID: 8529246
    [No Abstract]   [Full Text] [Related]  

  • 33. Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare?
    Moran A; Goldman L
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):606-7. PubMed ID: 18695697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE inhibitors in acute myocardial infarction.
    Murdoch DR; McMurray JJ
    Hosp Med; 1998 Feb; 59(2):111-5. PubMed ID: 9797884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H; Searles G; Gillis A
    Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective.
    Spencer F; Scleparis G; Goldberg RJ; Yarzebski J; Lessard D; Gore JM
    Am Heart J; 2001 Oct; 142(4):594-603. PubMed ID: 11579348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
    ; ; ; Smith SC; Allen J; Blair SN; Bonow RO; Brass LM; Fonarow GC; Grundy SM; Hiratzka L; Jones D; Krumholz HM; Mosca L; Pearson T; Pfeffer MA; Taubert KA
    J Am Coll Cardiol; 2006 May; 47(10):2130-9. PubMed ID: 16697342
    [No Abstract]   [Full Text] [Related]  

  • 39. [Secondary prevention in patients before and after percutaneous transluminal coronary angioplasty: 5-year follow-up].
    Muntwyler J; Maschio Andrist M; Amann FW
    Schweiz Med Wochenschr; 1997 Apr; 127(14):573-8. PubMed ID: 9198883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombolytic treatment of acute myocardial infarct. 3].
    Gabriel HM; Soares-Costa JT; Soares-Costa TJ
    Acta Med Port; 1998 May; 11(5):431-8. PubMed ID: 9951053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.